This is consistent with a later age of onset described in a cohort of sporadic clinical MEN-1 patients with negative testing for MEN1 mutations which included all phenotypes of MEN-1, but only few with acromegaly (21). This evidence concerns the gene MEN1 and multiple endocrine neoplasia type 1.